<?xml version="1.0" encoding="UTF-8"?>

<MedicinalProductDefinition xmlns="http://hl7.org/fhir">
  <id value="Cefuroxime-MIP-1500mg-EE-MPD"/>
  <meta>
    <profile value="http://unicom-project.eu/fhir/StructureDefinition/PPLMedicinalProductDefinition"/>
  </meta>
  <text>
    <status value="generated"/><div xmlns="http://www.w3.org/1999/xhtml"><p><b>Generated Narrative: MedicinalProductDefinition</b><a name="Cefuroxime-MIP-1500mg-EE-MPD"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource MedicinalProductDefinition &quot;Cefuroxime-MIP-1500mg-EE-MPD&quot; </p><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-PPLMedicinalProductDefinition.html">PPL Medicinal Product profile</a></p></div><p><b>identifier</b>: id: EE-100009199-27834, id: EE0000002</p><p><b>domain</b>: Human use <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (100000000004#100000000012)</span></p><p><b>status</b>: Current <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (200000005003#200000005004)</span></p><p><b>combinedPharmaceuticalDoseForm</b>: Powder for solution for injection/infusion <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="CodeSystem-pharmaceutical-dose-form-ema-cs.html">Pharmaceutical Dose Form EMA</a>#100000116186)</span></p><p><b>legalStatusOfSupply</b>: Medicinal Product subject to medical prescription <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (100000072051#100000072084)</span></p><p><b>classification</b>: Cefuroxime <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (100000093533#100000096183; <a href="http://terminology.hl7.org/4.0.0/CodeSystem-v3-WC.html">WHO ATC</a>#J01DC02 &quot;cefuroxime&quot;)</span></p><blockquote><p><b>name</b></p><p><b>productName</b>: Cefuroxime MIP 1500 mg, süste-/infusioonilahuse pulber</p><blockquote><p><b>namePart</b></p><p><b>part</b>: Cefuroxime MIP</p><p><b>type</b>: Invented name part <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (220000000000#220000000002)</span></p></blockquote><blockquote><p><b>namePart</b></p><p><b>part</b>: 1500 MG</p><p><b>type</b>: Strength part <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (220000000000#220000000004)</span></p></blockquote><h3>CountryLanguages</h3><table class="grid"><tr><td>-</td><td><b>Country</b></td><td><b>Language</b></td></tr><tr><td>*</td><td>Republic of Estonia <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (100000000002#100000000388)</span></td><td>Estonian <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (100000072057#100000072172)</span></td></tr></table></blockquote></div>
  </text>
  <identifier>
    <system value="http://ema.europa.eu/fhir/mpId"/>
    <value value="EE-100009199-27834"/>
  </identifier>
  <identifier>
    <system value="http://ema.europa.eu/fhir/pmsId"/>
    <value value="EE0000002"/>
  </identifier>
  <domain>
    <coding>
      <system value="http://spor.ema.europa.eu/v1/lists/100000000004"/>
      <code value="100000000012"/>
      <display value="Human use"/>
    </coding>
  </domain>
  <status>
    <coding>
      <system value="http://spor.ema.europa.eu/v1/lists/200000005003"/>
      <code value="200000005004"/>
      <display value="Current"/>
    </coding>
  </status>
  <combinedPharmaceuticalDoseForm>
    <coding>
      <system value="http://spor.ema.europa.eu/v1/lists/200000000004"/>
      <code value="100000116186"/>
      <display value="Powder for solution for injection/infusion"/>
    </coding>
  </combinedPharmaceuticalDoseForm>
  <legalStatusOfSupply>
    <coding>
      <system value="http://spor.ema.europa.eu/v1/lists/100000072051"/>
      <code value="100000072084"/>
      <display value="Medicinal Product subject to medical prescription"/>
    </coding>
  </legalStatusOfSupply>
  <classification>
    <coding>
      <system value="http://spor.ema.europa.eu/v1/lists/100000093533"/>
      <code value="100000096183"/>
      <display value="Cefuroxime"/>
    </coding>
    <coding>
      <system value="http://www.whocc.no/atc"/>
      <code value="J01DC02"/>
      <display value="cefuroxime"/>
    </coding>
  </classification>
  <name>
    <productName value="Cefuroxime MIP 1500 mg, süste-/infusioonilahuse pulber"/>
    <namePart>
      <part value="Cefuroxime MIP"/>
      <type>
        <coding>
          <system value="http://spor.ema.europa.eu/v1/lists/220000000000"/>
          <code value="220000000002"/>
          <display value="Invented name part"/>
        </coding>
      </type>
    </namePart>
    <namePart>
      <part value="1500 MG"/>
      <type>
        <coding>
          <system value="http://spor.ema.europa.eu/v1/lists/220000000000"/>
          <code value="220000000004"/>
          <display value="Strength part"/>
        </coding>
      </type>
    </namePart>
    <countryLanguage>
      <country>
        <coding>
          <system value="http://spor.ema.europa.eu/v1/lists/100000000002"/>
          <code value="100000000388"/>
          <display value="Republic of Estonia"/>
        </coding>
      </country>
      <language>
        <coding>
          <system value="http://spor.ema.europa.eu/v1/lists/100000072057"/>
          <code value="100000072172"/>
          <display value="Estonian"/>
        </coding>
      </language>
    </countryLanguage>
  </name>
</MedicinalProductDefinition>